Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
Mark C. Sulavik(NKT Therapeutics (United States)), George H. Shimer(NKT Therapeutics (United States)), Christina Cramer(Bausch Health (United States)), Beth DiDomenico(Bausch Health (United States)), Chad Houseweart(NKT Therapeutics (United States)), Nilofer Jiwani(NKT Therapeutics (United States)), Karen Joy Shaw(Arcturus Therapeutics (United States)), Jonathan Greene(Claremont Graduate University), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), R S Hare, George H. Miller(Bausch Health (United States))
Cited by 502
Related Papers
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
|Biochemical Journal|2006|272
Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint
|Antimicrobial Agents and Chemotherapy|2001|242